Acrivon Competitors and Similar CompaniesClear all
Iksuda Therapeutics's competitors and similar companies include Numab.
 Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer. | ||
Founding Date | Founding Date 2007 | Founding Date 2011 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Newcastle upon Tyne, GB HQ Newton, US | Locations Wädenswil, CH HQ |
Employees | Employees 43 | Employees 681% decrease |
Funding | ||
Latest funding round | Latest funding round $ 47m (almost 5 years ago) | Latest funding round $ 110m (about 5 years ago) |
Total funding raised | Total funding raised $ 47m | Total funding raised $ 132.3m |
For sources of this data, please see the company profile
View Company Profiles
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease
Numab Therapeutics is an oncology-focused biopharmaceutical company.
View company